13th European Headache Congress

Migraine does not take lives but days from your life. Take them back!

Prof. Michelle Xiao Androulakis


Day of Lecture

June 2nd 10:30 - 10:50


Stroke and headache


Board Certified in American Board of Neurology and Psychiatry
Board certified in Headache Medicine

B.        Positions and Honors

  2014-2018                   Clinical Assistant professor, Director of Headache Clinic, SOM, University of South Carolina

2018-now                    Chief of Neurology, Medical Director of Stroke Program, Site Director for Neurology residency program at the Dorn VA Medical Center;

2018-now                    Adjunct assistant professor, Dept. of Neurology, SOM, University of South Carolina



1995          Travel scholarship for training course in Electro-Neurophysiology, University of Toronto        

1996          Travel scholarship for training course in Cell and Tissue Culture              

1994-1996 Canadian Neuroscience Network of Excellence Fellowship

2015          Travel award for International headache academy held at NIH               

2015          Travel award for ANA 7th Annual Translational Clinical Research Course for Clinician-Scientists    

2015, 2016, 2017, 2018          Top Doctors award, Columbia, SC                 

2017, 2018                                          Castle Connolly Exceptional Women award in Medicine                                

2018                Faculty of Scottsdale Headache Symposium

2017-now Fellow of American Headache Society (FAHS)

D.  Research Support       


Project pending IRB approval (site PI):                                                                                                     Oct.,2018- Oct. 2020

Phase 2, multi-center clinical trial using AVP-786-205 on neurobehavioral disinhibition in patients with TBI.


Projects completed (PI):

18450-JA13 (PI, investigator initiated) Sponsored by TX360             August, 2015-2018

Long term outcome and management of headache patients treated with Sphenopalatine Ganglion Block: A registry and functional MRI study

18450-JA17 (Site PI)                                                                                                                                                                         Dec, 2015-2018

Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 (Galcanezumab) in Patients with Episodic Migraine

18450-JA16 (Site PI)                                                                                                                                                                         Dec, 2015-2018

Phase 3, Randomized, Double-Blind, Placebo-Controlled study of LY2951742 (Galcanezumab) in Patients with Chronic Migraine

M-Award 13580-MMA1 (PI, investigator initiated)                                                                      April 2015- June 2016

McCausland Center (M-Fund) for new investigators

A prospective fMRI study on resting state brain activity in healthy subjects and in chronic migraine patients undergoing long term Sphenopalatine ganglion block

18450-E154 (PI, investigator initiated) USC ASPIRE GRANT               Jan 2016-Jan 2017

A prospective fMRI study on brain connectivity in healthy subjects and in chronic migraine patients undergoing long term Sphenopalatine ganglion

ASUBIO (Site PI)                                                                                                                                                                  Mar 2015-Mar 2016

A Phase 2, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SUN13837 Administered Doses (27/28 Days) to Adult Subjects with an Acute Ischemic Stroke

SOCRATEs (Site PI)                                                                                                                                                            May 2014- Dec. 2015

A Randomized, Double blind, multinational study to Prevent Major Vascular Events with Ticagrelor Compared to Aspirin (ASA) in Patients with Acute ischemic Stroke or TIA


Projects completed (sub-I):


Periodontal treatment to Eliminate Minority in Equality and Rural disparities in Stroke

Brains gate:

Augmenting Cerebral blood flow via Sphenopalatine ganglion stimulation Trial 


Multicenter, randomized, double-blind, double-dummy, active-comparator, event-driven, superiority phase III study of secondary prevention of stroke and prevention of systemic embolism in patients with a recent Embolic Stroke of Undetermined Source (ESUS), comparing rivaroxaban 15 mg once daily with aspirin 100 mg (NAVIGATE ESUS)

PRISMS: Efficacy and Safety of Alteplase in Mild Stroke: Rapidly Improving Symptoms & Minor Neurologic Deficits